Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
企業コードHLN
会社名Haleon PLC
上場日Jul 18, 2022
最高経営責任者「CEO」Mcnamara (Brian)
従業員数- -
証券種類Depository Receipt
決算期末Jul 18
本社所在地Building 5, First Floor
都市WEYBRIDGE
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United Kingdom
郵便番号KT13 0NY
電話番号441932822000
ウェブサイトhttps://www.haleon.com/
企業コードHLN
上場日Jul 18, 2022
最高経営責任者「CEO」Mcnamara (Brian)
過去5年間の配当金総支払額は
570.00M
米ドルである。
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
HLN.NB Interim Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
HLN.NB Final Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023